Literature DB >> 18093835

Synthesis and antiproliferative activity of benzyl and phenethyl analogs of makaluvamines.

Bidhan A Shinkre1, Kevin P Raisch, Liming Fan, Sadanandan E Velu.   

Abstract

Analogs of marine alkaloid, makaluvamine, bearing substituted benzyl and substituted phenethyl side chains have been synthesized and their antiproliferative activities have been evaluated. 4-Methyl, 4-chloro, and 4-fluoro substituted benzyl analogs possessed pronounced antiproliferative effects on the breast cancer cell line, MCF-7 at IC(50) values of 2.3 microM, 1.8 microM, and 2.8 microM, respectively. 4-Methyl, 4-chloro, and 3,4-methylenedioxy derivatives showed the best activity against MCF-7 among the phenethyl analogs with IC(50) values of 2.3 microM, 2.8 microM, and 2.4muM, respectively. In general, methoxy substitutions resulted in slight loss in activity in both benzyl and phenethyl series. Benzyl, 4-fluorobenzyl, 3,4-dimethoxyphenethyl, and 3,4-methylenedioxyphenethyl analogs were tested by NCI in their 60 cell lines in vitro human cancer cell screen. All four compounds showed excellent inhibition against several tested cancer cell lines. Benzyl and 4-fluorobenzyl analogs were relatively more active than 3,4-dimethoxy phenethyl and 3,4-methylenedioxy phenethyl analogs. In NCI assays, the best LogGI(50) values were shown by the fluorobenzyl analog against the renal cancer cell line RXF-393 (<-8.0M) and dimethoxy phenethyl analog against the CNS cancer cell line, SF-268 (<-8.0M). The best LogLC(50) value was shown by the fluorobenzyl analog against the breast cancer cell line MCF-7 (-6.01 M).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093835     DOI: 10.1016/j.bmc.2007.11.051

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  Total synthesis of zyzzyanones A-D.

Authors:  Dwayaja H Nadkarni; Srinivasan Murugesan; Sadanandan E Velu
Journal:  Tetrahedron       Date:  2013-05-20       Impact factor: 2.457

2.  Development and validation of an HPLC method for quantitation of BA-TPQ, a novel iminoquinone anticancer agent, and an initial pharmacokinetic study in mice.

Authors:  Haibo Li; Scharri J Ezell; Xiangrong Zhang; Wei Wang; Hongxia Xu; Elizabeth R Rayburn; Xu Zhang; Evrim Gurpinar; Xinyi Yang; Charnell I Sommers; Sadanandan E Velu; Ruiwen Zhang
Journal:  Biomed Chromatogr       Date:  2010-09-15       Impact factor: 1.902

3.  A facile synthesis of bispyrroloquinone and bispyrroloiminoquinone ring system of marine alkaloids.

Authors:  Srinivasan Murugesan; Dwayaja H Nadkarni; Sadanandan E Velu
Journal:  Tetrahedron Lett       Date:  2009-06-24       Impact factor: 2.415

Review 4.  Synthesis of the marine pyrroloiminoquinone alkaloids, discorhabdins.

Authors:  Yasufumi Wada; Hiromichi Fujioka; Yasuyuki Kita
Journal:  Mar Drugs       Date:  2010-04-21       Impact factor: 5.118

5.  Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.

Authors:  Scharri J Ezell; Haibo Li; Hongxia Xu; Xiangrong Zhang; Evrim Gurpinar; Xu Zhang; Elizabeth R Rayburn; Charnell I Sommers; Xinyi Yang; Sadanandan E Velu; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2010-07-13       Impact factor: 5.118

6.  A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.

Authors:  Wei Wang; Elizabeth R Rayburn; Sadanandan E Velu; Deng Chen; Dwayaja H Nadkarni; Srinivasan Murugesan; Dongquan Chen; Ruiwen Zhang
Journal:  Breast Cancer Res Treat       Date:  2009-11-21       Impact factor: 4.872

7.  FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.

Authors:  Feng Wang; Scharri J Ezell; Yong Zhang; Wei Wang; Elizabeth R Rayburn; Dwayaja H Nadkarni; Srinivasan Murugesan; Sadanandan E Velu; Ruiwen Zhang
Journal:  Invest New Drugs       Date:  2009-03-10       Impact factor: 3.850

8.  In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.

Authors:  Wei Wang; Elizabeth R Rayburn; Sadanandan E Velu; Dwayaja H Nadkarni; Srinivasan Murugesan; Ruiwen Zhang
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

9.  Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.

Authors:  Tao Chen; Yi Xu; He Guo; Yanling Liu; Pingting Hu; Xinying Yang; Xiaoguang Li; Shichao Ge; Sadanandan E Velu; Dwayaja H Nadkarni; Wei Wang; Ruiwen Zhang; Hui Wang
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

10.  Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog.

Authors:  Xiangrong Zhang; Hongxia Xu; Xu Zhang; Sukesh Voruganti; Srinivasan Murugesan; Dwayaja H Nadkarni; Sadanandan E Velu; Ming-Hai Wang; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2012-05-23       Impact factor: 6.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.